Hubungan Kontrasepsi Suntik Depo Medroxy Progesteron Asetat (DMPA) Dengan Pertambahan Berat Badan Di Wilayah Kerja Puskesmas Kertak Hanyar Kabupaten Banjar Tahun 2017
Abstract
Hormonal contraception is the most preferred type of contraception for family planning acceptors, especially injection contraceptives. Kertak Hanyar Health Center Family Planning Service Coverage January - October 2016 found 58.82% of injection contraceptive acceptors. The most commonly used injection contraceptive method is Depo Medroxy Progesterone Acetate (DMPA). These contraceptives are highly effective in preventing pregnancy, but have the main side effect of changing body weight. This study aims to determine the relationship between Depo Medroxy Progesterone Acetate (DMPA) injection contraception with weight gain in the Kertak Hanyar Public Health Center, Banjar Regency in 2017. The research method used is an analytical survey with aapproach cross sectional. The number of samples in this study were 99 injection contraceptive acceptors with the sampling technique using purposive sampling. The research instrument used a family planning card (KB card), weight scales and interviews. Data analysis was performed using thetest Chi Square with a confidence level of 95%. The results of the study of 64 respondents who used DMPA injection contraceptives the most experienced excess weight gain, namely 26 respondents (41%) and of the 35 respondents who used combined injection contraceptives the most experienced normal weight gain, namely 22 respondents (62.9%). The results of statistical tests showed that there was a relationship between injection contraceptive DMPA and weight gain of r = 0.038 < a = 0.05. Keywords: DMPA Injectable Contraception, Weight Gain
Copyright (c) 2021 Jurnal Skala Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with JURNAL SKALA KESEHATAN POLITEKNIK KESEHATAN BANJARMASIN (JSK) means that the author or authors retain the copyright in the paper. JSK granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by JSK in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage. JSK journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. JSK journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
